Navigation Links
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
Date:10/7/2008

ase is a strict gluten-free diet; however, the response to therapy is poor or incomplete in up to 30 percent of patients. These facts suggest that there is a need for therapeutic modalities beyond dietary modification.

Related data presented in a third poster at ACG include results from a qualitative study conducted to investigate the validity of the Gastrointestinal Symptom Rating Scale (GSRS) in patients with celiac disease. The GSRS is a validated measure used in clinical trials for irritable bowel syndrome and peptic ulcer disease. GSRS has been utilized in studies to assess larazotide acetate, including CLIN 1001-004 and CLIN 1001-006. Results from the poster presentation suggest that certain subscales of the GSRS may have relevance for use in establishing the efficacy of novel treatments for celiac disease. This is the first time the validity of the GSRS clinical scale has been studied in celiac disease to assess efficacy of treatments.

"There are currently no products approved by the FDA to treat celiac disease and a clear need exists for a therapeutic option," said Daniel Leffler, MD, gastroenterologist, Beth Israel Deaconess Medical Center and one of the lead investigators for CLIN 1001-004. "This study showed that larazotide acetate prevented immunologic changes induced by gluten in patients with celiac disease. In addition, studies to establish the validity of scales such as GSRS are an important step forward in the development of effective treatments for celiac disease."

"Alba is excited to be advancing the first therapy for celiac disease and we are encouraged by these breakthrough findings," said Dr. Francisco Leon, head of Clinical Research and Development at Alba Therapeutics, Inc. "These results will be further tested in Phase III clinical trials to evaluate safety, efficacy, and maintenance of effect of larazotide acetate in treating celiac disease. In addition, we are excited by early preclinical study results showing signs of
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
2. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
4. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
5. PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy
6. Data from In Vivo Disease Models on Taligen Therapeutics Pipeline Candidates to be Presented at the XXII International Complement Workshop
7. Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patients with Diabetes
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
10. Tobira Therapeutics Inc. Receives US Patent for TBR-652
11. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (NYSE: CVS ) officially announced today that it will rebuild ... fire damage during protests last week.  "As we watched ... past week or so, our hearts turned from pain to the ... Larry Merlo . "Our purpose as a company is helping ... way that we can fulfill that purpose than to reopen our ...
(Date:5/6/2015)... 6, 2015 Fibich, Leebron, Copeland, Briggs & ... settlement has been reached to resolve lawsuits involving individuals ... Actos. Actos - manufactured by Takeda Pharmaceuticals - has ... cancer. Several of the firm,s attorneys were instrumental in ... Tommy Fibich - Founding Partner of Fibich, ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. The ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... 15, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Inc. effected a one-for-twenty reverse stock split at 5:00 ... by the Financial Industry Regulatory Authority (FINRA) that FINRA ...
... and BALTIMORE, March 15, 2011 ... innovate, implement and commercialize next generation of medical image ... leading clinicians and advanced engineering technologists. ... international communications and information technology company, and Johns Hopkins ...
Cached Medicine Technology:Nephros Announces Split Adjusted Trade Date 2Nephros Announces Split Adjusted Trade Date 3Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2
(Date:5/7/2015)... Mamaroneck, NY (PRWEB) May 07, 2015 ... 100% natural ingredients, non-GMO, Gluten Free, Vegan, no preservatives, ... lovely handcrafted bottle, this perfumed gift will delight every ... in the US in 2011 and has grown successfully ... traditional soft drinks offers also multiple opportunities as cocktail ...
(Date:5/6/2015)... Device Patent Law Changes:, Six Key Areas of ... 12:30 p.m. EDT, http://www.fdanews.com/DevicePatentLaw , Every year, medical ... claims that waste their time. , It doesn't have ... prevented if devicemakers better understand the trouble spots to watch ... to patent laws from all around the world. , Why ...
(Date:5/6/2015)... 06, 2015 RPS Revolution - a game ... tried and true Rock Paper Scissors game - is now ... that encourage storytelling and easy to learn rules from Rock ... an old favorite. RPS Revolution takes the best ... characters that are grouped in set of three called Trios. ...
(Date:5/6/2015)... Mass. (PRWEB) May 06, 2015 ... today announced that CTO David Ting will lead a ... the associated data security and user authentication challenges, during ... Fla.). The session will focus on the benefits of ... in which care providers and patients can share information. ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after leaving ... while under the influence of Flakka, according to CBS ... CBS4’s Peter D’Oench records Doby distraught in a parking lot ... year old. The drug treatment center in Florida who found ... residents polled by CBS Miami express concern about the fate ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2
... A nano-technology researcher at the Massachusetts Institute of ... faster , better, cheaper and environmentally-friendly transistors, batteries, ... semiconductors for use in modern electrical devices. ... diseases like AIDS, polio, and influenza, and can ...
... in the middle of the night ? You wont have ... Korea. For you will have replacement drivers on call .,Thousands ... people and their cars home. ,,Their work has ... other major cities of South Korea that the national statistical ...
... have identified a new gene mutation that is associated ... is also known as Prick's disease . ... of the brain that control behaviour and language. Language ... symptoms. ,Unlike Alzheimer's disease, this Frontotemporal ...
... has revealed that individuals age 49 and older with ... age-related macular degeneration appear to have higher mortality ... visual impairments. ,Several studies have shown associations ... older individuals. ,"The mechanisms for higher mortality ...
... Z partied so hard that the 'Beautiful Liar' star could not ... of the bottle . ,Last week, the 'Dangerously in ... ,A source said that the 25-year-old said that she did ... glass. ,"Beyonc? said she didn't mind - she didn't ...
... African fish signal their amorous intentions by exchanging bursts of ... ,Scientists describe this behavior as being somewhat similar to ... study, which has been reported by National Geographic, these fish ... ,Until now, the love life of electric ...
Cached Medicine News:Health News:Replacement Drivers Lend a Helping Hand to the Drunk and Stranded in Korea 2Health News:Replacement Drivers Lend a Helping Hand to the Drunk and Stranded in Korea 3Health News:Scientists Identify New Genetic Mutation Behind Common Dementia 2Health News:Visual Impairment Linked to Greater Mortality Risk 2Health News:Amorous African Fish Exchange Electric Pulses While Mating 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: